LSE company dividends information has been updated. You can find this is in the menu on any Quote page. ADVFN team.


Oncocyte Corp

0.00 (0.0%)

Oncocyte Financial Summary

The current 0KCC market cap is 302.48M. The company's latest EPS is 0 and P/E is -0.35.

Year End 31 December 20182019202020212022
Total Revenue 005.23M7.73M31.98M
Operating Income -15.2M-22.52M-31.26M-74.48M-18M
Net Income -15.75M-22.43M-29.93M-64.1M-73.42M
Year End 31 December 20182019202020212022
Total Assets 9.52M39.86M55.42M159.56M100.09M
Total Liabilities 6.1M9.02M21.94M94.35M60.5M
Total Equity 3.42M30.84M33.48M65.22M34.29M
Year End 31 December 20182019202020212022
Operating -11.65M-19.72M-25.98M-35.94M-45.57M
Investing -31k-12.42M-11.75M-13.96M-4.34M
Financing 12.11M47.87M22.8M78.75M35.81M
Market Cap 302.48M
Price to Earnings Ratio -0.35
Price to Sales Ratio 0.79
Price to Cash Ratio 1.26
Price to Book Ratio 0.64
Dividend Yield -

Share Statistics

Shares Outstanding 118.62M
Average Volume (1 week) 34
Average Volume (1 Month) 545
52 Week Change 0.0%
52 Week High 2.55
52 Week Low 2.55
Spread (Intraday) 0 (0%)

Company Info

Company Name Oncocyte Corp
Address 15 cushing
irvine, california 92618
Industry in vitro,in vivo diagnostics (2835)
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: +44 (0) 203 8794 460 |

V: D: 20230601 22:48:06